Ten life sciences board directors on AI's three hardest questions: developing the next generation of talent, accountability for speed, and board fluency.
Ray Pressburger
Advertisement
Ray Pressburger is the Global Industry Lead for Accenture in Life Sciences. He has spent over 20 years working across the industry on commercialization and transformations across nearly every therapeutic area and company and is currently focusing the industry team at Accenture on reinventing companies with AI.
Articles by Ray Pressburger
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
340B Under Pressure: Inside Pharma's Push for Greater Clarity
3
The Agentic AI Revolution in Biopharma
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5